Stocks
Zynerba Pharmaceuticals (ZYNE) ROE US GAAP (year values) |
|||||||||
| FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | LTM ? | CAGR 5 years ? | |||
| ROE, % | ? | -69.3% | -41.6% | -83.8% | -53.0% | -75.3% | -127.5% | ||
| Changes by years, y/y, % | -17pp | +28pp | -42pp | +31pp | -22pp | +7.5% | |||
Zynerba Pharmaceuticals. ROE, %
Zynerba Pharmaceuticals. ROE, changes, pp
Zynerba Pharmaceuticals (ZYNE) ROE US GAAP (quarter values) |
||||||||
| FY2022Q2 | FY2022Q3 | FY2022Q4 | FY2023Q1 | FY2023Q2 | LTM ? | |||
| ROE, % | ? | -67.1% | -69.6% | -76.8% | -94.4% | -127.5% | -127.5% | |
| Changes by years, y/y, % | -25pp | -21pp | -24pp | -36pp | -60pp | |||
| Changes by quarters, q/q, % | -9pp | -2pp | -7pp | -18pp | -33pp | |||
